- Home
- MMSI vs ELAN Comparison
MMSI vs ELAN Comparison
Compare MMSI & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMSI
- ELAN
- Stock Information
- Founded
- MMSI 1987
- ELAN 1954
- Country
- MMSI United States
- ELAN United States
- Employees
- MMSI N/A
- ELAN N/A
- Industry
- MMSI Medical/Dental Instruments
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- MMSI Health Care
- ELAN Health Care
- Exchange
- MMSI Nasdaq
- ELAN Nasdaq
- Market Cap
- MMSI 5.8B
- ELAN 6.0B
- IPO Year
- MMSI 1990
- ELAN 2018
- Fundamental
- Price
- MMSI $91.98
- ELAN $13.48
- Analyst Decision
- MMSI Buy
- ELAN Buy
- Analyst Count
- MMSI 9
- ELAN 6
- Target Price
- MMSI $109.11
- ELAN $15.17
- AVG Volume (30 Days)
- MMSI 497.7K
- ELAN 6.0M
- Earning Date
- MMSI 07-31-2025
- ELAN 08-07-2025
- Dividend Yield
- MMSI N/A
- ELAN N/A
- EPS Growth
- MMSI 17.19
- ELAN N/A
- EPS
- MMSI 2.04
- ELAN 0.75
- Revenue
- MMSI $1,388,357,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- MMSI $11.68
- ELAN $4.28
- Revenue Next Year
- MMSI $6.27
- ELAN $4.67
- P/E Ratio
- MMSI $45.11
- ELAN $17.96
- Revenue Growth
- MMSI 8.19
- ELAN 1.42
- 52 Week Low
- MMSI $80.84
- ELAN $8.02
- 52 Week High
- MMSI $111.45
- ELAN $18.55
- Technical
- Relative Strength Index (RSI)
- MMSI 38.40
- ELAN 56.01
- Support Level
- MMSI $92.31
- ELAN $13.32
- Resistance Level
- MMSI $94.42
- ELAN $14.15
- Average True Range (ATR)
- MMSI 1.77
- ELAN 0.38
- MACD
- MMSI -0.24
- ELAN -0.16
- Stochastic Oscillator
- MMSI 5.31
- ELAN 27.11
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.